Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acorda Therapeutics Inc.

    NASDAQ: ACOR · Real-Time Price · USD
    0.66
    -0.21 (-24.14%)
    At close: Apr 03, 2024, 3:59 PM

    Acorda Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 117.63M 118.57M 129.07M
    Cost of Revenue
    		 46.05M 30.33M 40.79M
    Gross Profit
    		 71.59M 88.23M 88.28M
    Operating Income
    		 -23.26M -42.04M -77.3M
    Interest Income
    		 530K 1.91M 5K
    Pretax Income
    		 -296.02M -35.25M -109.07M
    Net Income
    		 -252.85M -65.92M -103.95M
    Selling & General & Admin
    		 89.7M 106.26M 124.4M
    Research & Development
    		 5.15M 5.8M 10.42M
    Other Expenses
    		 51K 18.21M 30.76M
    Operating Expenses
    		 94.85M 130.27M 165.58M
    Interest Expense
    		 31.53M 28.29M 30.04M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 140.9M 160.6M 206.37M
    Income Tax Expense
    		 -43.17M 30.67M -5.12M
    Shares Outstanding (Basic)
    		 1.24M 985.35K 531.05K
    Shares Outstanding (Diluted)
    		 1.24M 985.35K 531.05K
    EPS (Basic)
    		 -203.59 -66.9 -195.75
    EPS (Diluted)
    		 -203.59 -66.9 -195.75
    EBITDA
    		 8.4M -10.03M -44.8M
    EBIT
    		 -233.49M -6.71M -95.66M
    Depreciation & Amortization
    		 31.67M 32.01M 32.5M

    Add to Watchlist